Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

SHA/688581 stock hub

SHA/688581 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/688581is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.1B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/688581

In the news

Latest news · SHA/688581

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E22.9

P25 23.5P50 41.3P75 83.2

ROE8.8

P25 -0.9P50 4.1P75 8.8

ROIC26.8

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/688581 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

CNY

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	856
Employees Change	112%
Employees Change Percent	15.05
Enterprise value	CNY 3.2B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Medical Devices
Isin	CNE100005ZF0
Last refreshed	2026-05-10
Market cap	CNY 5.1B
Price	CNY 63.38
Price currency	CNY
Rev Per Employee	813,955.58x
Sector	Healthcare
Sic	3841
Symbol	sha/688581
Website	https://www.bioags.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.34%
EV Earnings	14.27x
EV/EBIT	14.12x
EV/EBITDA	13.17x
EV/FCF	23.94x
EV/Sales	5.24x
FCF yield	2.59%
P/B ratio	1.99x
P/E ratio	22.92x
P/S ratio	8.45x
PE Ratio3 Y	23.22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	37.1%
EBITDA Margin	39.57%
FCF margin	21.88%
Gross margin	70.78%
Gross Profit	CNY 428.6M
Gross Profit Growth	-8.78%
Gross Profit Growth Q	7.22%
Gross Profit Growth3 Y	17.48%
Net Income	CNY 222.3M
Net Income Growth	-25.13%
Net Income Growth Q	0.97%
Net Income Growth3 Y	13.57%
Pretax Margin	43.44%
Profit Margin	36.7%
Profit Per Employee	CNY 298,737
ROA	5.34
Roa5y	13.93
ROCE	8.71
ROE	8.83
Roe5y	25.17
ROIC	26.8
Roic5y	103.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	7.92%
EPS Growth	-24.87
EPS Growth Q	1.45
EPS Growth3 Y	3.4
FCF Growth	-50.54%
FCF Growth Q	5,302.74%
FCF Growth3 Y	13.71%
OCF Growth	-34.69%
OCF Growth Q	672.3%
OCF Growth3 Y	10.76%
Revenue Growth	-7.36x
Revenue Growth Q	9.21x
Revenue Growth3 Y	16.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.23
Assets	CNY 2.7B
Cash	CNY 2B
Current Assets	CNY 2.1B
Current Liabilities	CNY 119.4M
Debt	CNY 31.8M
Debt EBITDA	CNY 0.13
Debt Equity	CNY 0.01
Debt FCF	CNY 0.24
Equity	CNY 2.6B
Liabilities	CNY 127.2M
Long Term Assets	CNY 610.8M
Long Term Liabilities	CNY 7.9M
Net Cash	CNY 1.9B
Net Cash By Market Cap	CNY 37.97
Net Cash Growth	12.43%
Net Debt EBITDA	CNY -8.11
Net Debt Equity	CNY -0.76
Net Debt FCF	CNY -14.66
Tangible Book Value	CNY 2.5B
Tangible Book Value Per Share	CNY 31.12
WACC	7.41

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	17.48
Inventory Turnover	3.06
Net Working Capital	CNY 25.2M
Quick ratio	16.93
Working Capital	CNY 2B
Working Capital Turnover	CNY 0.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.35%
Dividend Growth	-5.28%
Dividend Growth Years	0%
Dividend per share	CNY 1.37
Dividend Years	3
Dividend Yield	2.17%
Ex Div Date	2025-07-09
Last Dividend	CNY 1.37
Payout Frequency	Annual
Payout Ratio	50.04%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	7.91%
200-day SMA	65.02
50-day SMA	57.23
50-day SMA vs 200-day SMA	50under200
All Time High	98.29
All Time High Change	-35.51%
All Time High Date	2023-05-23
All Time Low	42.92
All Time Low Change	47.67%
All Time Low Date	2024-02-06
ATR	1.82
Beta	0.58
Beta1y	0.65
Beta2y	0.51
Ch YTD	8.1
High	63.66
High52	88.96
High52 Date	2025-08-21
High52ch	-28.75%
Low	59.88
Low52	52.4
Low52 Date	2026-03-23
Low52ch	20.95%
Ma50ch	10.74%
Price vs 200-day SMA	-2.53%
RSI	69.83
RSI Monthly	47.18
RSI Weekly	55.93
Sharpe ratio	0.06x
Sortino ratio	0.29
Total Return	2.51%
Tr YTD	8.1
Tr1m	17.31%
Tr1w	4.99%
Tr3m	3.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 224.7M
Operating Income Growth	-24.5
Operating Income Growth Q	1.61
Operating Income Growth3 Y	12.35
Operating margin	37.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	55,188,342%
Net Borrowing	30,000,000
Shares Insiders	7.18%
Shares Institutions	6.17%
Shares Out	80,720,181
Shares Qo Q	3.26%
Shares Yo Y	-0.35%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 132.5M
Average Volume	834,232.45x
Bv Per Share	31.71
CAPEX	CNY -69.3M
Ch1m	17.31
Ch1w	4.99
Ch1y	5.63
Ch3m	3.65
Ch6m	3.38
Change	5.11%
Change From Open	5.04
Close	60.3
Days Gap	0.07
Depreciation Amortization	14,956,982
Dollar Volume	102,849,641.5
Earnings Date	2026-04-23
EBIT	CNY 224.7M
EBITDA	CNY 239.6M
EPS	CNY 2.76
F Score	3
FCF	CNY 132.5M
FCF EV Yield	4.18x
FCF Per Share	CNY 1.64
Financing CF	-61,881,371
Fiscal Year End	December
Founded	2,010
Graham Number	44.41504
Graham Upside	-29.92
Income Tax	CNY 41.3M
Investing CF	172,024,405
Is Primary Listing	1
Last Earnings Date	2026-04-23
Last Report Date	2026-03-31
Last Split Date	2024-06-21
Last Split Type	Forward
Lynch Fair Value	CNY 37.52
Lynch Upside	-40.8
Ma150	61.13
Ma150ch	3.68%
Ma20	57.93
Ma20ch	9.4%
Net CF	302,117,659
Next Earnings Date	2026-08-07
Open	60.34
P FCF Ratio	38.61
P OCF Ratio	25.35
Payment Date	2025-07-09
Position In Range	92.59
Ppne	208,399,122
Price Date	2026-05-08
Price EBITDA	CNY 21.35
Ptbv Ratio	2.03
Relative Volume	1.95x
Revenue	605,582,948x
Tax By Revenue	6.82x
Tax Rate	15.7%
Tr6m	3.38%
Volume	1,622,746

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/688581 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.2%

$1.37 annual per share

Payout ratio

+50.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+2.5%

Next ex-dividend date: 2025-07-09

Performance

SHA/688581 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/688581?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.2%

Share of float held by funds and institutions

Insider ownership

+7.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.3%

Negative means the company is buying back shares.

Technical

SHA/688581 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

69.8

Neutral momentum band

Price vs 200-day MA

-2.5%

50/200-day relationship not available

Beta (5Y)

0.58

Less volatile than the market

Sharpe ratio

0.06

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/688581

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/688581 stock rating?

sha/688581 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/688581 analysis?

The full report lives at /stocks/sha/688581/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/688581?

The latest report frames sha/688581 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/688581 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.